Bank Of New York Mellon Corp Vir Biotechnology, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $16.7 Million - $23.6 Million	836,400 New	836,400 $21.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $512,996 - $873,723	28,094 Added 4.0%	730,087 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $8.16 Million - $11.4 Million	427,490 Added 155.73%	701,993 $17.9 Million
Q1 2022 May 11, 2022	SELL	$21.19 - $40.01 $92,833 - $175,283	-4,381 Reduced 1.57%	274,503 $7.06 Million
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $530,578 - $925,641	17,132 Added 6.55%	278,884 $11.7 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $762,948 - $1.19 Million	21,861 Added 9.11%	261,752 $11.4 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $2.66 Million - $3.5 Million	68,585 Added 40.04%	239,891 $11.3 Million
Q1 2021 May 13, 2021	SELL	$26.34 - $83.07 $261,266 - $823,971	-9,919 Reduced 5.47%	171,306 $8.78 Million
Q4 2020 Feb 09, 2021	BUY	$25.51 - $43.38 $413,746 - $703,580	16,219 Added 9.83%	181,225 $4.85 Million
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $1.16 Million - $2.21 Million	41,176 Added 33.25%	165,006 $5.66 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $2.91 Million - $4.99 Million	104,213 Added 531.24%	123,830 $5.07 Million
Q1 2020 May 06, 2020	BUY	$12.04 - $60.2 $80,354 - $401,774	6,674 Added 51.56%	19,617 $672,000
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $153,115 - $205,146	12,943 New	12,943 $162,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.